Indometacin Accord-Uk (Indometacin)

Indometacin blocks the activity of cyclooxygenase enzymes (COX‑1 and COX‑2), which are essential for converting arachidonic acid into prostaglandins. By lowering prostaglandin production, the drug diminishes the inflammatory response, reduces pain signaling, and helps control fever associated with inflammatory conditions.

The exact dose and frequency of Indometacin Accord-Uk are determined by the prescribing healthcare professional based on the patient’s specific condition, severity of symptoms, age, renal and hepatic function, and any concurrent medications. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

The safety of indometacin during pregnancy and lactation has not been clearly established. It is generally avoided, especially in the third trimester, because of potential risks to the fetus and newborn. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternative therapies with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com indicating the required quantity of Indometacin Accord-Uk. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Indometacin is a potent NSAID with a relatively strong anti‑inflammatory effect, often used when rapid symptom control is needed. Compared with ibuprofen, it may have a higher risk of gastrointestinal and renal side effects, but it can be more effective for certain conditions like gout. Choice of agent depends on efficacy, safety profile, and patient‑specific factors.

Indometacin Accord-Uk suppositories should be stored at ambient temperature, below 25 °C, in the original packaging. Keep them away from moisture, direct sunlight and excessive heat to maintain product stability and potency throughout the shelf life.

The medication is supplied as a rectal suppository. The patient inserts the suppository into the rectum, preferably after a bowel movement, and allows it to dissolve completely. Administration instructions, including the number of suppositories per dose, are provided by the prescribing clinician.

Serious risks include gastrointestinal ulceration or bleeding, severe liver injury, acute kidney failure, cardiovascular events such as heart attack or stroke, and rare but life‑threatening skin reactions like Stevens‑Johnson syndrome. Patients should be monitored for signs of these conditions and seek immediate medical attention if they occur.

Individuals with known hypersensitivity to indometacin or other NSAIDs, active peptic ulcer disease, severe heart failure, uncontrolled hypertension, significant renal or hepatic impairment, and those in the third trimester of pregnancy should avoid using Indometacin Accord-Uk. The prescriber should evaluate each patient’s medical history before initiating therapy.